CELH

Celsius Holdings, Inc.

72
Fundamentals87/ 100
Valuation70/ 100
Upside potential73/ 100
Risk potential26/ 100

CELH offers stronger valuation, but that advantage does not outweigh its weaker overall profile.

SKHY

SK hynix Inc.

79
Fundamentals95/ 100
Valuation50/ 100
Upside potentialUnknown
Risk potentialUnknown

SKHY has the edge over CELH overall, supported by stronger fundamentals.

CELH Fundamentals

MetricStatus
Healthy
Strong
Stable
Strong

CELH's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.

SKHY Fundamentals

MetricStatus
Strong
Strong
Strong
Strong

SKHY's revenue, profitability, cash flow and balance sheet are all currently strong.

CELH PE Valuation

CHEAPFAIREXPENSIVE318x636x954x1272x
CHEAPFAIREXPENSIVE318x636x954x1272x
LevelPEPriceVs current
Forward21x$31.89—
Current35x$31.89—
Cheap40x$35.95+13%
Fair141x$127+299%
Expensive650x$585+1735%

Historical ranges are pointers, not guarantees.

CELH's PE is in its cheap range at 35x. If earnings grow as analysts expect, today's price would be 21x next year's earnings.

SKHY PE Valuation

SKHY has no meaningful PE right now: it lost money over the past year.

CELH Forward outlook

MetricOutlook
Strongly improving
Strong growth
Growth
Improving
Limited
Low

Analysts expect earnings and revenue growth for CELH, with profitability improving. However, they disagree widely on these estimates.

SKHY Forward outlook

MetricOutlook
--
Strong growth
Strong growth
Strongly improving
Limited
Low

Analysts expect strong earnings and revenue growth for SKHY, with profitability improving. However, they disagree widely on these estimates.

CELH Risk to reward

ScenarioChangePrice
Upside+69%$54.01
Downside-25%$23.76

Calculated from the latest close: $31.89 on Nov 12.

There is not enough scenario data to compare CELH and SKHY's risk to reward.

SKHY Risk to reward

ScenarioChangePrice
UpsideUnknown—
DownsideUnknown—

Calculated from the latest close: $137.71 on Nov 12.

There is not enough scenario data to compare CELH and SKHY's risk to reward.

CELH Earnings Per Share

Q4 2023: $0.77Q1 2024: $0.91Q2 2024: $1.01Q3 2024: $0.72Q4 2024: $0.45Q1 2025: $0.33Q2 2025: $0.38Q3 2025: $0.11Q4 2025: $0.25Q1 2026: $0.43Q2 2026: $0.24Q3 2026: $0.90Forward: $1.53
Q4 2023: $0.77Q1 2024: $0.91Q2 2024: $1.01Q3 2024: $0.72Q4 2024: $0.45Q1 2025: $0.33Q2 2025: $0.38Q3 2025: $0.11Q4 2025: $0.25Q1 2026: $0.43Q2 2026: $0.24Q3 2026: $0.90Forward: $1.53
QuarterTTM EPSYoY
Forward$1.53+70%
Q3 2026$0.90+718%
Q2 2026$0.24-37%
Q1 2026$0.43+30%
Q4 2025$0.25-44%
Q3 2025$0.11-85%
Q2 2025$0.38-62%
Q1 2025$0.33-64%
Q4 2024$0.45-42%

CELH earned $0.90 per share over the past year, about eight times what it earned the year before.

SKHY Earnings Per Share

Q3 2023: $-1.25Q4 2023: $-0.99Q1 2024: $-0.50Q2 2024: $0.27Q3 2024: $1.10Q4 2024: $2.12Q1 2025: $2.76Q2 2025: $3.04Q3 2025: $3.78Q4 2025: $4.52Q1 2026: $7.91Q2 2026: $17.04
Q3 2023: $-1.25Q4 2023: $-0.99Q1 2024: $-0.50Q2 2024: $0.27Q3 2024: $1.10Q4 2024: $2.12Q1 2025: $2.76Q2 2025: $3.04Q3 2025: $3.78Q4 2025: $4.52Q1 2026: $7.91Q2 2026: $17.04
QuarterTTM EPSYoY
Q2 2026$17.04+461%
Q1 2026$7.91+187%
Q4 2025$4.52+113%
Q3 2025$3.78+244%
Q2 2025$3.04+1026%
Q1 2025$2.76+$3.26
Q4 2024$2.12+$3.11
Q3 2024$1.10+$2.35

SKHY has the edge over CELH on earnings, with more consistent year-over-year improvement.

CELH Quarterly Revenue

Q4 2023: $347MQ1 2024: $356MQ2 2024: $402MQ3 2024: $266MQ4 2024: $332MQ1 2025: $329MQ2 2025: $739MQ3 2025: $725MQ4 2025: $722MQ1 2026: $783MQ2 2026: $818MQ3 2026: $847M
Q4 2023: $347MQ1 2024: $356MQ2 2024: $402MQ3 2024: $266MQ4 2024: $332MQ1 2025: $329MQ2 2025: $739MQ3 2025: $725MQ4 2025: $722MQ1 2026: $783MQ2 2026: $818MQ3 2026: $847M
QuarterRevenueYoY
Q3 2026$847.2M+17%
Q2 2026$817.9M+11%
Q1 2026$782.6M+138%
Q4 2025$721.6M+117%
Q3 2025$725.1M+173%
Q2 2025$739.3M+84%
Q1 2025$329.3M-7.4%
Q4 2024$332.2M-4.4%

CELH's revenue has grown year over year for six quarters in a row: $847M last quarter, up 17% from the same quarter a year ago.

SKHY Quarterly Revenue

Q3 2023: $6.8BQ4 2023: $8.5BQ1 2024: $9.3BQ2 2024: $12.3BQ3 2024: $13.2BQ4 2024: $14.8BQ1 2025: $13.2BQ2 2025: $16.7BQ3 2025: $18.3BQ4 2025: $24.6BQ1 2026: $39.4BQ2 2026: $59.4B
Q3 2023: $6.8BQ4 2023: $8.5BQ1 2024: $9.3BQ2 2024: $12.3BQ3 2024: $13.2BQ4 2024: $14.8BQ1 2025: $13.2BQ2 2025: $16.7BQ3 2025: $18.3BQ4 2025: $24.6BQ1 2026: $39.4BQ2 2026: $59.4B
QuarterRevenueYoY
Q2 2026$59.4B+257%
Q1 2026$39.4B+198%
Q4 2025$24.6B+66%
Q3 2025$18.3B+39%
Q2 2025$16.7B+35%
Q1 2025$13.2B+42%
Q4 2024$14.8B+75%
Q3 2024$13.2B+94%

SKHY has the edge over CELH on sales, with more consistent year-over-year improvement.

CELH Free Cash Flow

Q4 2023: $426,000Q1 2024: $130MQ2 2024: $30MQ3 2024: $9MQ4 2024: $70MQ1 2025: $96MQ2 2025: $35MQ3 2025: $321MQ4 2025: −$130MQ1 2026: $66MQ2 2026: $205MQ3 2026: $128M
Q4 2023: $426,000Q1 2024: $130MQ2 2024: $30MQ3 2024: $9MQ4 2024: $70MQ1 2025: $96MQ2 2025: $35MQ3 2025: $321MQ4 2025: −$130MQ1 2026: $66MQ2 2026: $205MQ3 2026: $128M
QuarterFree cash flowYoY
Q3 2026$127.7M-60%
Q2 2026$205.5M+479%
Q1 2026$65.8M-32%
Q4 2025-$130M-285%
Q3 2025$321.5M+3599%
Q2 2025$35.5M+17%
Q1 2025$96.4M-26%
Q4 2024$70.3M+16394%

CELH still generates free cash flow, though less than at its 2025 peak: $269M over the past year.

SKHY Free Cash Flow

Q3 2023: −$438MQ4 2023: $1.6BQ1 2024: $1.6BQ2 2024: $2.7BQ3 2024: $3BQ4 2024: $2.7BQ1 2025: $1.9BQ2 2025: $3.4BQ3 2025: $6.8BQ4 2025: $6.5BQ1 2026: $13.8BQ2 2026: $41.2B
Q3 2023: −$438MQ4 2023: $1.6BQ1 2024: $1.6BQ2 2024: $2.7BQ3 2024: $3BQ4 2024: $2.7BQ1 2025: $1.9BQ2 2025: $3.4BQ3 2025: $6.8BQ4 2025: $6.5BQ1 2026: $13.8BQ2 2026: $41.2B
QuarterFree cash flowYoY
Q2 2026$41.2B+1111%
Q1 2026$13.8B+619%
Q4 2025$6.5B+142%
Q3 2025$6.8B+127%
Q2 2025$3.4B+26%
Q1 2025$1.9B+20%
Q4 2024$2.7B+67%
Q3 2024$3B+$3.4B

SKHY has the edge over CELH on cash flow, with more consistent year-over-year improvement.

CELH Total Shares

Q4 2023: 237MQ1 2024: 238MQ2 2024: 238MQ3 2024: 234MQ4 2024: 237MQ1 2025: 237MQ2 2025: 260MQ3 2025: 258MQ4 2025: 255MQ1 2026: 260MQ2 2026: 257MQ3 2026: 255M
Q4 2023: 237MQ1 2024: 238MQ2 2024: 238MQ3 2024: 234MQ4 2024: 237MQ1 2025: 237MQ2 2025: 260MQ3 2025: 258MQ4 2025: 255MQ1 2026: 260MQ2 2026: 257MQ3 2026: 255M
PeriodChange %Net change
Quarterly-0.8%-2M shares
1 year-1.1%-2.9M shares
3 years+7.4%+17.6M shares
5 years+8.3%+19.5M shares
Available history+32%+62.4M shares

CELH has the edge over SKHY on shareholder dilution, with a more favorable share count trend.

SKHY Total Shares

Q3 2023: 6.9BQ4 2023: 6.9BQ1 2024: 6.9BQ2 2024: 7.1BQ3 2024: 7.1BQ4 2024: 6.9BQ1 2025: 6.9BQ2 2025: 7.1BQ3 2025: 7.1BQ4 2025: 7.1BQ1 2026: 7.1BQ2 2026: 7.1B
Q3 2023: 6.9BQ4 2023: 6.9BQ1 2024: 6.9BQ2 2024: 7.1BQ3 2024: 7.1BQ4 2024: 6.9BQ1 2025: 6.9BQ2 2025: 7.1BQ3 2025: 7.1BQ4 2025: 7.1BQ1 2026: 7.1BQ2 2026: 7.1B
PeriodChange %Net change
Quarterly+0.2%+14.8M shares
1 year+0.2%+14.8M shares
3 years+3.7%+254M shares
5 years+3.9%+268M shares
Available history+4.3%+294M shares

SKHY has 7.1B diluted shares, about the same as a year ago.

CELH Net Leverage

Q4 2023: -2.8xQ1 2024: -2.9xQ2 2024: -2.7xQ3 2024: -3.8xQ4 2024: -5.5xQ1 2025: -7.3xQ2 2025: 1.4xQ3 2025: 0.5xQ4 2025: 1.6xQ1 2026: 0.5xQ2 2026: 0.2xQ3 2026: -0.1x
Q4 2023: -2.8xQ1 2024: -2.9xQ2 2024: -2.7xQ3 2024: -3.8xQ4 2024: -5.5xQ1 2025: -7.3xQ2 2025: 1.4xQ3 2025: 0.5xQ4 2025: 1.6xQ1 2026: 0.5xQ2 2026: 0.2xQ3 2026: -0.1x
QuarterNet LeverageStatus
Q3 2026-0.1xNet Cash
Q2 20260.2xVery low
Q1 20260.5xVery low
Q4 20251.6xHealthy
Q3 20250.5xVery low
Q2 20251.4xHealthy
Q1 2025-7.3xNet Cash
Q4 2024-5.5xNet Cash

CELH has more cash than debt.

SKHY Net Leverage

Q3 2023: 23.3xQ4 2023: 7.2xQ1 2024: 2.7xQ2 2024: 1.2xQ3 2024: 0.6xQ4 2024: 0.4xQ1 2025: 0.3xQ2 2025: 0.3xQ3 2025: 0.3xQ4 2025: 0.2xQ1 2026: 0.0xQ2 2026: -0.0x
Q3 2023: 23.3xQ4 2023: 7.2xQ1 2024: 2.7xQ2 2024: 1.2xQ3 2024: 0.6xQ4 2024: 0.4xQ1 2025: 0.3xQ2 2025: 0.3xQ3 2025: 0.3xQ4 2025: 0.2xQ1 2026: 0.0xQ2 2026: -0.0x
QuarterNet LeverageStatus
Q2 2026-0.0xNet Cash
Q1 20260.0xVery low
Q4 20250.2xVery low
Q3 20250.3xVery low
Q2 20250.3xVery low
Q1 20250.3xVery low
Q4 20240.4xVery low
Q3 20240.6xVery low

SKHY has more cash than debt.

CELH Weekly Momentum

MetricValueStatus
RSI51.3Neutral
Stochastic56.8Neutral

CELH's weekly RSI is 51 (neutral) and its Stochastic is 57 (neutral).

SKHY Weekly Momentum

MetricValueStatus
RSI28.7Oversold
Stochastic19.7Oversold

SKHY's weekly RSI is 29 (oversold) and its Stochastic is 20 (oversold).

CELH PE vs Consumer Defensive Sector

MetricCELHSector medianRelative
PE35x19x82% above
PE %11187 pts below

CELH is trading at 35x earnings, a 82% premium to the Consumer Defensive sector's median of 19x.

SKHY PE vs Technology Sector

SKHY has no meaningful PE right now: it lost money over the past year.

CELH Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$29.19.4% above
20 week MA$29.67.8% above
50 week MA$36.112% below
100 week MA$38.818% below
200 week MA$44.629% below

CELH has stronger trend alignment. CELH is above 2 of 5 weekly averages versus SKHY above 0 of 1.

SKHY Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$155.411% below

SKHY is in a downtrend: it's below all one of its weekly moving averages, and 11% below its 8-week average.

CELH Yearly ROI

YearStart priceEnd priceROI
2020$1.58$14.7+832%
2021$14.7$24.9+69%
2022$24.9$35.6+43%
2023$35.6$54.5+53%
2024$54.5$26.5-51%
2025$26.5$45.6+72%
2026 YTD$45.6$31.9-30%

CELH's yearly returns have swung widely, from +832% in 2020 to −51% in 2024. It's down 30% so far in 2026.

SKHY Yearly ROI

YearStart priceEnd priceROI
2026 YTD$168.0$137.7-18%

SKHY has the edge over CELH on returns for 2026, with the stronger performance.

Give your agent the market.

Get API key